Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Aug 7, 2014; 20(29): 9759-9774
Published online Aug 7, 2014. doi: 10.3748/wjg.v20.i29.9759
Published online Aug 7, 2014. doi: 10.3748/wjg.v20.i29.9759
Specific metabolic biomarkers as risk and prognostic factors in colorectal cancer
Małgorzata Muc-Wierzgoń, Ewa Nowakowska-Zajdel, Sylwia Dzięgielewska-Gęsiak, Teresa Kokot, Katarzyna Klakla, Edyta Fatyga, Department of Internal Diseases, Medical University of Silesia, 41-902 Bytom, Poland
Elżbieta Grochowska-Niedworok, Department of Human Nutrition, Medical University of Silesia, 41-902 Bytom, Poland
Dariusz Waniczek, Department of Gastrointestinal Surgery, Medical University of Silesia, 41-902 Bytom, Poland
Janusz Wierzgoń, Department of Oncological and Reconstructive Surgery, Center of Oncology Maria Skłodowska-Curie Memorial Institute in Warsaw, Branche Gliwice, 41-121 Gliwice, Poland
Author contributions: Both authors substantially contributed to the article and approved the final version to be published.
Correspondence to: Małgorzata Muc-Wierzgoń, Professor, Department of Internal Diseases, Medical University of Silesia, st. Żeromskiego 7, 41-902 Bytom, Poland. mwierzgon@sum.edu.pl
Telephone: +48-32-2812122 Fax: +48-32-2812122
Received: September 28, 2013
Revised: January 20, 2014
Accepted: April 21, 2014
Published online: August 7, 2014
Processing time: 313 Days and 6.5 Hours
Revised: January 20, 2014
Accepted: April 21, 2014
Published online: August 7, 2014
Processing time: 313 Days and 6.5 Hours
Core Tip
Core tip: We describe the metabolic candidates of colorectal cancer: Dyslipidemias, adipokines and insulin/insulin-like growth factor axis as a potential risk and prognostic biomarkers.